Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols

BACKGROUND: Nerve damage in leprosy often causes disabilities and deformities. Prednisolone is used to treat nerve function impairment (NFI). However, optimal dose and duration of prednisolone treatment has not been established yet. Besides treating existing NFI it would be desirable to prevent NFI....

Descripción completa

Detalles Bibliográficos
Autores principales: Wagenaar, Inge, Brandsma, Wim, Post, Erik, van Brakel, Wim, Lockwood, Diana, Nicholls, Peter, Saunderson, Paul, Smith, Cairns, Wilder-Smith, Einar, Richardus, Jan Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547773/
https://www.ncbi.nlm.nih.gov/pubmed/23249098
http://dx.doi.org/10.1186/1471-2377-12-159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547773/
https://www.ncbi.nlm.nih.gov/pubmed/23249098
http://dx.doi.org/10.1186/1471-2377-12-159

Ejemplares similares